SER

Handel nachbörslich: 1.94 0.02 +1.04%

Serina Therapeutics Inc (SER)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Serina Therapeutics Inc Stock (SER) Company Profile

Serina Therapeutics Inc

Healthcare (1111)

Biotechnology (621)

(256) 327-9630

601 GENOME WAY, HUNTSVILLE

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SER's Discussions on Twitter

Compare SER vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SER Serina Therapeutics Inc	1.92	29.70M	130.00K	-19.22M	-18.01M	-1.8946
VRTX Vertex Pharmaceuticals Inc	435.93	110.28B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	634.62	66.98B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	808.43	50.15B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	295.50	39.71B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	154.89	32.22B	742.00K	-1.37B	-1.07B	-7.0731

Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-14	Eingeleitet	H.C. Wainwright	Buy

Serina Therapeutics Inc Aktie (SER) Neueste Nachrichten

Finanzdaten der Serina Therapeutics Inc-Aktie (SER)

Serina Therapeutics Inc (SER)

Serina Therapeutics Inc Stock (SER) Company Profile

Compare SER vs VRTX, REGN, ARGX, ALNY, RVMD

Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades

Serina Therapeutics Inc Aktie (SER) Neueste Nachrichten

Director boosts stake in Serina Therapeutics (SER) with 20K-share buy - Stock Titan

Serina Therapeutics Inc (SER) Q1 2026 Earnings: EPS Miss Amid Continued Development ProgressFinancial Summary - Newser

Serina Therapeutics Q1 2026 Earnings: EPS Misses Estimates as Stock Climbs Despite LossGAAP Earnings Report - Newser

Serina Therapeutics Inc. (SER) Recovers 4.93% as Stock Approaches Key Resistance at $2.08Volume Spike Alerts - Newser

Serina Therapeutics Inc. (SER) Gains Nearly 5% as Stock Approaches Key ResistanceTop Analyst Buy Signals - Newser

Director at Serina Therapeutics (SER) makes open-market buy of 12,183 shares - Stock Titan

16.45M Serina shares registered for resale (NYSE: SER) - Stock Titan

Serina Therapeutics : Enable Injections Announces CE Certification of the enFuse® On-Body Delivery System for Use with Aspaveli® Distributed by Sobi - marketscreener.com

SER Stock Price, Quote & Chart | SERINA THERAPEUTICS INC. (NYSEARCA:SER) - ChartMill

Serina Therapeutics (SER) Gets a Buy from JonesTrading - The Globe and Mail

Insider-Backed PIPE Deal May Dilute Serina Therapeutics Shareholders and Heighten Governance Risks - The Globe and Mail

Serina Therapeutics (SER) stock surges over 39% after hours—here's why - MSN

Serina Therapeutics 1Q Loss/Shr 58c >SER - Moomoo

Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates - The Manila Times

Parkinson's drug trial moves ahead as Serina adds $21.2M funding - Stock Titan

Serina Therapeutics (NYSE: SER) raises $21.2M and advances SER-252 trial - Stock Titan

Serina Therapeutics (NYSE: SER) posts Q1 loss and raises $21.2M PIPE amid cash risk - Stock Titan

Serina Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

SER Technical Analysis | Trend, Signals & Chart Patterns | SERINA THERAPEUTICS INC. (NYSEARCA:SER) - ChartMill

MSN Money - MSN

TradingKey - TradingKey

What Serina Therapeutics (SER) is doing to stay ahead (Slight Loss) 2026-05-08Social Trade Signals - newser.com

How Serina Therapeutics (SER) responds when competition intensifies (Volatility Increases) 2026-05-08Community Buy Alerts - newser.com

The recurring revenue story behind Serina Therapeutics (SER) | Q4 2025: EPS Exceeds ExpectationsPut/Call Ratio - newser.com

Sio Capital (SER) reports 1,000,000 shares, 6.71% stake in Serina Therapeutics - Stock Titan

Serina Therapeutics (SER) Stock: Is It a Strong Investment Pick | Q4 2025: Earnings Beat EstimatesTrending Entry Points - newser.com

Chart Pattern Insight | Serina Therapeutics notches 33% EPS beat, tops loss estimatesPost Earnings - newser.com

Serina Therapeutics (NYSE: SER) seeks share increase and equity plan changes in 2026 proxy - Stock Titan

Serina Therapeutics Updates Executive Leadership and Governance Structure - The Globe and Mail

Finanzdaten der Serina Therapeutics Inc-Aktie (SER)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SER